% | $
Quotes you view appear here for quick access.

Organovo Holdings, Inc. Message Board

  • jgmtruth jgmtruth Oct 22, 2013 12:52 PM Flag

    Organovo says 3D human liver product on track for 2014 launch

    Earlier today, Organovo Holdings provided a summary of the data presented at the 3rd Annual Cell Therapy Bioprocessing Conference in Bethesda, MD International Bioprocessing Conference on October 22. The demonstration of extended function in Organovo's 3D liver tissues was achieved faster than Organovo's projected timeline of achieving these results by the end of 2013 and highlights progress in the development of a 3D Human Liver product, which is on track for launch in 2014. The company believes that a multi-cellular bioprinted 3D Liver system with extended life span in culture can provide superior results to current human cellular models and offer significant value to pharmaceutical researchers by enabling assessment of both biochemical and tissue responses. Shares of Organovo are up over 7% to $6.69 in midday trading.

    Sentiment: Strong Buy

3.77Sep 29 4:00 PMEDT